Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)

202470 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov Identifier: NCT04606602.

Good health and well-being

Published in: JAMA

Volume 331, Issue 18, pp. 1534-1534

Field-Weighted Citation Impact: 39.72